Emerging Treatments and Maintenance Strategies in Ovarian Cancer

This chapter delves into maintenance therapy options for ovarian cancer patients post-chemotherapy, emphasizing drugs like olaparib, bevacizumab, and Mervituximab sorvetansine. It highlights the importance of genetic markers and explores emerging therapies' potential to improve outcomes for those with recurrent disease.